Tazawa Y, Noguchi H, Nishinomiya F, Takada G
Department of Pediatrics, Akita University School of Medicine, Japan.
Acta Paediatr Jpn. 1997 Apr;39(2):210-4. doi: 10.1111/j.1442-200x.1997.tb03583.x.
To examine the effect of weight changes on serum transaminase activities, glutamic oxaloacetic and pyruvic transaminases (GOT/GPT), a 3-month observation of 110 obese outpatients treated by a mild regimen for obesity was carried out. Patients were divided into two major groups, group I (n = 73) and group II (n = 37), with or without persistent elevation of serum GOT/GPT (> 30 IU/L), and retrospectively classified into four subgroups according to weight changes: group A, weight loss > 5%; group B, weight loss of < 5%; group C, an increase of < 5%; group D, an increase > 5%. In group IA, the incidence of cases with normalization of serum GOT/GPT was 70% and was significantly greater than those of the other three subgroups, respectively (P < 0.01). The incidences of decreased serum GOT/GPT activities were observed corresponding to the degree of weight changes not only in group I (100-27%) but also in group II (100-33%). These facts indicate that a mild regimen for obese outpatients for 3 months, significantly improves serum transaminase activities in patients not only with weight reduction but also weight gain, and that fatty liver may be present even in obese children with normal serum transaminase levels. The normalization of serum GPT activity in patients with weight gain suggests the presence of another factor contributing hypertransaminasemia in pediatric obese patients.
为研究体重变化对血清转氨酶活性(谷草转氨酶/谷丙转氨酶,GOT/GPT)的影响,对110例接受轻度肥胖治疗方案的肥胖门诊患者进行了为期3个月的观察。患者分为两大组,第一组(n = 73)和第二组(n = 37),根据血清GOT/GPT是否持续升高(> 30 IU/L),并根据体重变化回顾性分为四个亚组:A组,体重减轻> 5%;B组,体重减轻< 5%;C组,体重增加< 5%;D组,体重增加> 5%。在IA组中,血清GOT/GPT恢复正常的病例发生率为70%,显著高于其他三个亚组(P < 0.01)。不仅在第一组(100% - 27%),而且在第二组(100% - 33%)中,均观察到血清GOT/GPT活性降低的发生率与体重变化程度相对应。这些事实表明,对肥胖门诊患者进行3个月的轻度治疗方案,不仅能显著改善体重减轻患者的血清转氨酶活性,也能改善体重增加患者的血清转氨酶活性,并且即使血清转氨酶水平正常的肥胖儿童也可能存在脂肪肝。体重增加患者血清GPT活性恢复正常表明,小儿肥胖患者高转氨酶血症可能存在其他促成因素。